Severe Asthma Proves Too Much Of A Challenge For Vectura
Executive Summary
An ambitious trial of a budesonide-based drug/device combo for uncontrolled asthma has failed, but Vectura is upbeat as it switches resources to a potential pediatric asthma treatment.